@AHealthBlog tweets related to: Evidence, Benefits, Memantine, Disease, Alzheimers

An analysis of studies involving the drug memantine finds a lack of evidence for benefit when the drug is used to treat patients with mild Alzheimer's disease."Memantine, indicated for moderate to severe Alzheimer's disease is frequently prescribed off-label [for uses other than those approved by the FDA] either alone or with a cholinesterase inhibitor for mild Alzheimer's disease and mild cognitive impairment," the authors write as background information in the article.
A Health Blog Twitter

No Evidence for Benefit of Memantine in Mild #Alzheimers Disease http://t.co/5w2RtTeyTy

A Health Blog Twitter

See what's Trending Now for @AHealthBlog

See All Trending »
A Health Blog

Follow @AHealthBlog on Twitter